<DOC>
	<DOC>NCT01203956</DOC>
	<brief_summary>There will be equivalent therapeutic effectiveness between SmartFlex and standard modes when using the DeVilbiss AutoAdjust device.</brief_summary>
	<brief_title>DeVilbiss AutoAdjust With SmartFlex Comparative Study</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Epworth Sleepiness Scale &gt;10 Body Mass Index &gt; 26 Apneahypopnea index (AHI) ≥15 (mod to severe range) AHI ≤ 10 at therapeutic continuous positive airway pressure (CPAP) pressure CPAP naïve patients Polysomnogram (PSG) within 3 months of enrollment Average oxygen saturation by pulse oximetry (SpO2) &gt; 90% during titration Sleep efficiency on titration night ≥ 78% Diagnosis of mild obstructive sleep apnea (OSA) Comorbid conditions which render participation to be at risk these may include patients with congestive heart failure, chronic obstructive pulmonary disease (COPD) or psychiatric illness Allergies to mask materials Difficulties with nasal breathing Evidence of another primary sleep disorder Evidence of arousing periodic limb movements during titration Contraindications as listed on product labeling. Pregnant Currently diagnosed with depression if symptomatic Predominately central sleep apnea Deemed medically unsuitable by investigator Evidence of any type of infection or treatment of an infectious condition during the period of research participation Full Face Mask during titration Have a bilevel requirement CPAP pressure &gt;15cmH2O Subjects with tracheotomy Uncontrolled hypertension Require supplemental oxygen Stimulants, major tranquillizers or antipsychotics.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>AutoAdjust</keyword>
	<keyword>SmartFlex</keyword>
	<keyword>Apnea Hypopnea Index</keyword>
	<keyword>Patient reported outcomes</keyword>
</DOC>